Differences in the applicability of the Easson-Stedman hypothesis to the α1- and α2-adrenergic effects of phenethylamines and imidazolines-Reference-Cited by-同舟云学术

Differences in the applicability of the Easson-Stedman hypothesis to the α1- and α2-adrenergic effects of phenethylamines and imidazolines

Published:1983-01 Issue:3-4 Volume:86 Page:471-475
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ruffolo Robert R.,Rice Peter J.,Patil Popat N.,Hamada Akihiko,Miller Duane D.

Publisher

Elsevier BV

Subject

Pharmacology

Reference10 articles.

1. Pharmacological characterization of presynaptic α-adrenoceptors regulating cholinergic activity in guinea pig ileum;Drew;Br. J. Pharmacol.,1978

2. CLXX. Studies on the relationship between chemical constitution and physiological activity;Easson;Biochem. J.,1933

3. Molecular geometry and adrenergic drug activity;Patil;Pharmacol. Rev.,1974

4. Stereoselectivity in adrenergic agonists and adrenergic blocking agents;Ruffolo,1983

5. Receptor interactions of imidazolines. II. Affinities and efficacies of hydroxy-substituted tolazoline derivatives in rat aorta;Ruffolo;J. Pharmacol. Exp. Ther.,1979

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Concise and Useful Guide to Understand How Alpha1 Adrenoceptor Antagonists Work;Mini-Reviews in Medicinal Chemistry;2022-10

2. Pharmacological characterization of the α_2A-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency;Journal of Receptors and Signal Transduction;2022-08-19

3. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure;International Journal of Molecular Sciences;2021-05-28

4. Current Developments on the Role of α1-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism;Frontiers in Cell and Developmental Biology;2021-05-25

5. Modeling the Interactions Between α1-Adrenergic Receptors and Their Antagonists;Current Computer Aided-Drug Design;2010-09-01